市場調查報告書
商品編碼
1321040
數位生物製造市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測,按技術、按應用、最終用戶、公司和地區細分Digital Biomanufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Technology, By Application, By End User, By Company and By Region |
預計全球數位生物製造市場在2023-2027年預測期內將出現令人印象深刻的成長。主要因素包括各行業自動化進程的不斷提高、醫療保健行業向數位化和生物製造的轉變以及技術的廣泛發展,這些都抑制了市場的成長。數位生物製造是指在製造過程中使用數位技術,例如電腦輔助設計(CAD)和電腦輔助加工(CAM)。這些技術的應用有助於提高品質、功效和安全標準。支持市場成長的其他因素包括廣泛的研究和開發、對生物製劑的需求不斷增加、對減少錯誤、成本和時間的日益重視、私營和公共部門的各種投資、公司之間合作的數量不斷增加、和契約製造組織,特別是在新興國家。
在過去的幾年裡,各公司所採用的過時方法面臨著許多挑戰。因此,一些公司選擇自動化流程。自動化不斷融入工作環境推動市場的成長。這有助於提高大量工業流程的效率和高品質以及生產率。自動化在致力於開發新的治療干涉措施(例如藥物開發、細胞療法等)的應用研究實驗室中也發揮著重要作用。例如,Arctoris 是一家完全自動化的平台公司,它使用機器人、人工智慧和區塊鏈來生成強大、可靠、可重複的資料,並促進藥物發現中更好的決策。它還與藥物發現資產的內部管道合作,並與全球生物技術和製藥公司以及學術中心建立了有效的合作夥伴關係。
製藥和生物技術公司以及研究實驗室的工具和技術的快速進步促進全球數位生物製造市場的成長。人工智慧、數位孿生、智慧工作流程和機器人等數位工具整合到設備中,可以更輕鬆地最佳化製造流程。由於對生產力交付和生物治療行銷的高需求,數位製造流程的採用有所增加。此外,技術驅動型行業(主要是拋棄式技術和資訊技術公司)之間的併購有所增加。私人市場參與者、行業政府和學術組織之間越來越多的合作和夥伴關係也限制了現代生物製造技術的採用。加強市場的成長。例如,Cytiva 採用了Rockwell Automation PlantPAx系統,並利用自己的 Unicorn 軟體來實現其生物程序設備的自動化。資料可透過 MES 應用程式存取,並可合併以涵蓋電子批次記錄、調度等。
全球數位生物製造市場分為技術、應用、最終用戶和公司。根據技術,市場分為人工智慧和物聯網解決方案、過程分析技術、資料分析軟體等。根據應用,市場分為生物製造過程自動化和控制、生物過程最佳化和過程分析以及軟性製造。根據最終用戶,市場分為生物技術和製藥公司、學術和研究機構等。就國家而言,由於美國廣泛的技術發展,預計在預測期內美國將成為一個利潤豐厚的市場。
Agilent Technologies, Inc.、Danaher Corporation、Donaldson Company, Inc.、SAP SE、Honeywell International Inc.、Emerson Electric Company、Siemens、Healthineers AG、Atos SE、GE Healthcare 和 e-Matica srl 是在市場上營運中的一些領先公司。
根據給定的市場資料,TechSci Research 可根據公司的具體需求提供客製化服務。本報告可以使用以下自定義選項:
The global digital biomanufacturing market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include the rising automation process in various industries, the shift toward digitalization and biomanufacturing in the healthcare industry, and extensive development in technology, which are curbing the market'smarket's growth. Digital Biomanufacturing refers to the use of digital technologies in manufacturing processes, for instance, computer-aided design (CAD) and computer-assisted machining (CAM). The application of these technologies assists in improving quality, efficacy, and safety standards. The other factors supporting the market'smarket's growth are the extensive research and development, increasing demand for biologics, rising emphasis on reduction in errors, cost, and time, various investments by private as well public sectors, the growing number of collaborations between companies, and contract manufacturing organizations, particularly in emerging countries.
Over the past few years, numerous challenges have been faced by the outdated methods practiced by various companies. Therefore, several companies are opting for automation processes. The ongoing integration of automation into work environments is bolstering the growth of the market. This aids the efficiency and high quality of a massive array of industrial processes and production rates. Automation also plays an essential role in laboratories that deals with applied research that strives to develop new therapeutic interventions such as pharmaceutical developments, cell-based therapies, and others. For instance, Arctoris is a fully automated platform company that uses robotics, Artificial Intelligence, and blockchain to produce robust, reliable, reproducible data and facilitate better decisions in drug discovery. It also works with an internal pipeline of drug discovery assets and effective partnerships with biotech and pharma firms, as well as academic centers, globally.
Rapid advancements in the tools and techniques in pharmaceutical and biotechnology companies and research laboratories are augmenting the growth of the digital biomanufacturing market globally. Digital tools such as AI, digital twins, smart workflows, and robotics are integrated into equipment to make it easier to optimize the manufacturing process. Owing to the high demand for productivity delivery and marketing biotherapeutics, there is a rise in the adoption of digital manufacturing processes. Furthermore, there is a rise in mergers and acquisitions among technology-driven industries, mainly single-use technologies and information technology firms. A rising number of collaborations and partnerships between private market players, industry-government, and academic organizations are also curbing the adoption of modern technologies for biomanufacturing. Thus, in turn, strengthening the growth of the market. For instance, Cytiva adopted the Rockwell Automation PlantPAx system and utilized its own Unicorn software to automate its bioprocess equipment. Data is made accessible through MES applications and can be combined to incorporate electronic batch records, scheduling, and more.
The global digital biomanufacturing market is segmented into technology, application, end-user, and company. Based on technology, the market is segmented into AI & IOMT solutions, process analytical technologies, data analytics software, and others. Based on application, the market is segmented into biomanufacturing process automation and control, bioprocess optimization and process analytics, and flexible manufacturing. Based on end users, the market is divided into biotechnology & pharmaceutical companies, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the extensive technology development in the country.
Agilent Technologies, Inc., Danaher Corporation, Donaldson Company, Inc., SAP SE, Honeywell International Inc., Emerson Electric Company, Siemens, Healthineers AG, Atos SE, GE Healthcare, and e-Matica srl are some of the leading companies operating in the market.
In this report, global digital biomanufacturing market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Global Digital Biomanufacturing Market
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: